MOLECULAR CANCER THERAPEUTICS-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=568376, encodeId=8e8e5683e675, content=QC已经好几天了，还没变，请问有人遇到过这种情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d80e2509318, createdName=124b6ef5m61(暂无昵称), createdTime=Wed Mar 20 00:00:00 CST 2019, time=2019-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568115, encodeId=ad8656811550, content=请问你的QC问题最后怎么样了？我也遇到了类似的问题，不知是否正常？sky110319 2018-11-06 15:04:00 发表: 请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？, beContent=sky110319 2018-11-06 15:04:00 发表: 请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d80e2509318, createdName=124b6ef5m61(暂无昵称), createdTime=Fri Mar 15 00:00:00 CST 2019, time=2019-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566739, encodeId=0b76566e3983, content=楼下ccr转投这个太亏了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Thu Feb 14 09:50:00 CST 2019, time=2019-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566335, encodeId=e0fb566335eb, content=请问要求提供WB原始无裁剪图吗？husttjxusen_72292323 2017-11-16 发表:: 研究方向：小分子药物;; 审稿时间：约2个月 SCI(2016)：5.764 SCI(2015)：5.579 SCI(2014)：5.683 做药物靶向肿瘤微环境方向。9月27投稿，当天QC，当天under review，11月3号decision pending，11号收到意见，两个reviewer，没有为难，小修，要求三个月修回。估计内容比较对口。husttjxusen_72292323 2017-11-16 09:51:00 发表: 做药物靶向肿瘤微环境方向。9月27投稿，当天QC，当天under review，11月3号decision pending，11号收到意见，两个reviewer，没有为难，小修，要求三个月修回。估计内容比较对口。, beContent=husttjxusen_72292323 2017-11-16 发表:: 研究方向：小分子药物;; 审稿时间：约2个月 SCI(2016)：5.764 SCI(2015)：5.579 SCI(2014)：5.683 做药物靶向肿瘤微环境方向。9月27投稿，当天QC，当天under review，11月3号decision pending，11号收到意见，两个reviewer，没有为难，小修，要求三个月修回。估计内容比较对口。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/20/4c9024110b1652c063c0636bc187da8e.jpg, createdBy=10402290533, createdName=121e5b9fm00(暂无昵称), createdTime=Wed Jan 30 00:00:00 CST 2019, time=2019-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565522, encodeId=95c5565522d3, content=CCR转投的，之前在CCR under review 后第二天被拒，转投这个，已经9天了，这个杂志一般多久送外审，或者第一轮被拒啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK0iclWFtP7WicKXLyVXAOnRibMria0BwB4otV2d2ibbbkZ2XKAvnNH5x3Y1wm9ibMNZZV5ib5qA0B99sMpw/132, createdBy=9a062530214, createdName=yelinlin, createdTime=Sun Jan 13 16:29:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565540, encodeId=6dde5655407b, content=请问同学：你文章的命运如何？sky110319 2018-11-06 发表:: 请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？sky110319 2018-11-06 15:04:00 发表: 请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？, beContent=sky110319 2018-11-06 发表:: 请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41be2522582, createdName=124e1d81m04暂无昵称, createdTime=Sun Jan 13 00:00:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562815, encodeId=83695628156d, content=请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Tue Nov 06 15:04:00 CST 2018, time=2018-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562425, encodeId=07505624255e, content=收的。一颗苹果宣布成为星球 2018-09-26 00:00:00 发表: 请问这个杂志收版面费么？, beContent=一颗苹果宣布成为星球 2018-09-26 00:00:00 发表: 请问这个杂志收版面费么？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160620/IMG5767F7B4941608075.jpg, createdBy=16081612750, createdName=nnnuclear, createdTime=Sat Oct 27 00:00:00 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561460, encodeId=e24656146004, content=对数据要求高，编辑要求提供原始没有裁剪的western blot条带, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08d5109305, createdName=zhello1234, createdTime=Wed Sep 26 07:26:00 CST 2018, time=2018-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561480, encodeId=57aa561480ed, content=请问这个杂志收版面费么？husttjxusen_72292323 2018-08-30 00:00:00 发表: 推荐, beContent=husttjxusen_72292323 2018-08-30 00:00:00 发表: 推荐, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/09/16/436a088294e7cf59c36ee2e7d817c303.jpg, createdBy=8e2c2443753, createdName=一颗苹果宣布成为星球, createdTime=Wed Sep 26 00:00:00 CST 2018, time=2018-09-26, status=1, ipAttribution=)]

2019-03-20 124b6ef5m61(暂无昵称)

QC已经好几天了，还没变，请问有人遇到过这种情况吗？

167 0

[GetPortalCommentsPageByObjectIdResponse(id=568376, encodeId=8e8e5683e675, content=QC已经好几天了，还没变，请问有人遇到过这种情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d80e2509318, createdName=124b6ef5m61(暂无昵称), createdTime=Wed Mar 20 00:00:00 CST 2019, time=2019-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568115, encodeId=ad8656811550, content=请问你的QC问题最后怎么样了？我也遇到了类似的问题，不知是否正常？sky110319 2018-11-06 15:04:00 发表: 请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？, beContent=sky110319 2018-11-06 15:04:00 发表: 请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d80e2509318, createdName=124b6ef5m61(暂无昵称), createdTime=Fri Mar 15 00:00:00 CST 2019, time=2019-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566739, encodeId=0b76566e3983, content=楼下ccr转投这个太亏了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Thu Feb 14 09:50:00 CST 2019, time=2019-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566335, encodeId=e0fb566335eb, content=请问要求提供WB原始无裁剪图吗？husttjxusen_72292323 2017-11-16 发表:: 研究方向：小分子药物;; 审稿时间：约2个月 SCI(2016)：5.764 SCI(2015)：5.579 SCI(2014)：5.683 做药物靶向肿瘤微环境方向。9月27投稿，当天QC，当天under review，11月3号decision pending，11号收到意见，两个reviewer，没有为难，小修，要求三个月修回。估计内容比较对口。husttjxusen_72292323 2017-11-16 09:51:00 发表: 做药物靶向肿瘤微环境方向。9月27投稿，当天QC，当天under review，11月3号decision pending，11号收到意见，两个reviewer，没有为难，小修，要求三个月修回。估计内容比较对口。, beContent=husttjxusen_72292323 2017-11-16 发表:: 研究方向：小分子药物;; 审稿时间：约2个月 SCI(2016)：5.764 SCI(2015)：5.579 SCI(2014)：5.683 做药物靶向肿瘤微环境方向。9月27投稿，当天QC，当天under review，11月3号decision pending，11号收到意见，两个reviewer，没有为难，小修，要求三个月修回。估计内容比较对口。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/20/4c9024110b1652c063c0636bc187da8e.jpg, createdBy=10402290533, createdName=121e5b9fm00(暂无昵称), createdTime=Wed Jan 30 00:00:00 CST 2019, time=2019-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565522, encodeId=95c5565522d3, content=CCR转投的，之前在CCR under review 后第二天被拒，转投这个，已经9天了，这个杂志一般多久送外审，或者第一轮被拒啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK0iclWFtP7WicKXLyVXAOnRibMria0BwB4otV2d2ibbbkZ2XKAvnNH5x3Y1wm9ibMNZZV5ib5qA0B99sMpw/132, createdBy=9a062530214, createdName=yelinlin, createdTime=Sun Jan 13 16:29:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565540, encodeId=6dde5655407b, content=请问同学：你文章的命运如何？sky110319 2018-11-06 发表:: 请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？sky110319 2018-11-06 15:04:00 发表: 请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？, beContent=sky110319 2018-11-06 发表:: 请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41be2522582, createdName=124e1d81m04暂无昵称, createdTime=Sun Jan 13 00:00:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562815, encodeId=83695628156d, content=请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Tue Nov 06 15:04:00 CST 2018, time=2018-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562425, encodeId=07505624255e, content=收的。一颗苹果宣布成为星球 2018-09-26 00:00:00 发表: 请问这个杂志收版面费么？, beContent=一颗苹果宣布成为星球 2018-09-26 00:00:00 发表: 请问这个杂志收版面费么？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160620/IMG5767F7B4941608075.jpg, createdBy=16081612750, createdName=nnnuclear, createdTime=Sat Oct 27 00:00:00 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561460, encodeId=e24656146004, content=对数据要求高，编辑要求提供原始没有裁剪的western blot条带, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08d5109305, createdName=zhello1234, createdTime=Wed Sep 26 07:26:00 CST 2018, time=2018-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561480, encodeId=57aa561480ed, content=请问这个杂志收版面费么？husttjxusen_72292323 2018-08-30 00:00:00 发表: 推荐, beContent=husttjxusen_72292323 2018-08-30 00:00:00 发表: 推荐, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/09/16/436a088294e7cf59c36ee2e7d817c303.jpg, createdBy=8e2c2443753, createdName=一颗苹果宣布成为星球, createdTime=Wed Sep 26 00:00:00 CST 2018, time=2018-09-26, status=1, ipAttribution=)]

2019-03-15 124b6ef5m61(暂无昵称)

请问你的QC问题最后怎么样了？我也遇到了类似的问题，不知是否正常？sky110319 2018-11-06 15:04:00 发表:
请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？

sky110319 2018-11-06 15:04:00 发表: 请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？

189 0

[GetPortalCommentsPageByObjectIdResponse(id=568376, encodeId=8e8e5683e675, content=QC已经好几天了，还没变，请问有人遇到过这种情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d80e2509318, createdName=124b6ef5m61(暂无昵称), createdTime=Wed Mar 20 00:00:00 CST 2019, time=2019-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568115, encodeId=ad8656811550, content=请问你的QC问题最后怎么样了？我也遇到了类似的问题，不知是否正常？sky110319 2018-11-06 15:04:00 发表: 请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？, beContent=sky110319 2018-11-06 15:04:00 发表: 请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d80e2509318, createdName=124b6ef5m61(暂无昵称), createdTime=Fri Mar 15 00:00:00 CST 2019, time=2019-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566739, encodeId=0b76566e3983, content=楼下ccr转投这个太亏了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Thu Feb 14 09:50:00 CST 2019, time=2019-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566335, encodeId=e0fb566335eb, content=请问要求提供WB原始无裁剪图吗？husttjxusen_72292323 2017-11-16 发表:: 研究方向：小分子药物;; 审稿时间：约2个月 SCI(2016)：5.764 SCI(2015)：5.579 SCI(2014)：5.683 做药物靶向肿瘤微环境方向。9月27投稿，当天QC，当天under review，11月3号decision pending，11号收到意见，两个reviewer，没有为难，小修，要求三个月修回。估计内容比较对口。husttjxusen_72292323 2017-11-16 09:51:00 发表: 做药物靶向肿瘤微环境方向。9月27投稿，当天QC，当天under review，11月3号decision pending，11号收到意见，两个reviewer，没有为难，小修，要求三个月修回。估计内容比较对口。, beContent=husttjxusen_72292323 2017-11-16 发表:: 研究方向：小分子药物;; 审稿时间：约2个月 SCI(2016)：5.764 SCI(2015)：5.579 SCI(2014)：5.683 做药物靶向肿瘤微环境方向。9月27投稿，当天QC，当天under review，11月3号decision pending，11号收到意见，两个reviewer，没有为难，小修，要求三个月修回。估计内容比较对口。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/20/4c9024110b1652c063c0636bc187da8e.jpg, createdBy=10402290533, createdName=121e5b9fm00(暂无昵称), createdTime=Wed Jan 30 00:00:00 CST 2019, time=2019-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565522, encodeId=95c5565522d3, content=CCR转投的，之前在CCR under review 后第二天被拒，转投这个，已经9天了，这个杂志一般多久送外审，或者第一轮被拒啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK0iclWFtP7WicKXLyVXAOnRibMria0BwB4otV2d2ibbbkZ2XKAvnNH5x3Y1wm9ibMNZZV5ib5qA0B99sMpw/132, createdBy=9a062530214, createdName=yelinlin, createdTime=Sun Jan 13 16:29:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565540, encodeId=6dde5655407b, content=请问同学：你文章的命运如何？sky110319 2018-11-06 发表:: 请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？sky110319 2018-11-06 15:04:00 发表: 请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？, beContent=sky110319 2018-11-06 发表:: 请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41be2522582, createdName=124e1d81m04暂无昵称, createdTime=Sun Jan 13 00:00:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562815, encodeId=83695628156d, content=请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Tue Nov 06 15:04:00 CST 2018, time=2018-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562425, encodeId=07505624255e, content=收的。一颗苹果宣布成为星球 2018-09-26 00:00:00 发表: 请问这个杂志收版面费么？, beContent=一颗苹果宣布成为星球 2018-09-26 00:00:00 发表: 请问这个杂志收版面费么？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160620/IMG5767F7B4941608075.jpg, createdBy=16081612750, createdName=nnnuclear, createdTime=Sat Oct 27 00:00:00 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561460, encodeId=e24656146004, content=对数据要求高，编辑要求提供原始没有裁剪的western blot条带, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08d5109305, createdName=zhello1234, createdTime=Wed Sep 26 07:26:00 CST 2018, time=2018-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561480, encodeId=57aa561480ed, content=请问这个杂志收版面费么？husttjxusen_72292323 2018-08-30 00:00:00 发表: 推荐, beContent=husttjxusen_72292323 2018-08-30 00:00:00 发表: 推荐, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/09/16/436a088294e7cf59c36ee2e7d817c303.jpg, createdBy=8e2c2443753, createdName=一颗苹果宣布成为星球, createdTime=Wed Sep 26 00:00:00 CST 2018, time=2018-09-26, status=1, ipAttribution=)]

2019-02-14 bigapple001

楼下ccr转投这个太亏了

189 0

[GetPortalCommentsPageByObjectIdResponse(id=568376, encodeId=8e8e5683e675, content=QC已经好几天了，还没变，请问有人遇到过这种情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d80e2509318, createdName=124b6ef5m61(暂无昵称), createdTime=Wed Mar 20 00:00:00 CST 2019, time=2019-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568115, encodeId=ad8656811550, content=请问你的QC问题最后怎么样了？我也遇到了类似的问题，不知是否正常？sky110319 2018-11-06 15:04:00 发表: 请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？, beContent=sky110319 2018-11-06 15:04:00 发表: 请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d80e2509318, createdName=124b6ef5m61(暂无昵称), createdTime=Fri Mar 15 00:00:00 CST 2019, time=2019-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566739, encodeId=0b76566e3983, content=楼下ccr转投这个太亏了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Thu Feb 14 09:50:00 CST 2019, time=2019-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566335, encodeId=e0fb566335eb, content=请问要求提供WB原始无裁剪图吗？husttjxusen_72292323 2017-11-16 发表:: 研究方向：小分子药物;; 审稿时间：约2个月 SCI(2016)：5.764 SCI(2015)：5.579 SCI(2014)：5.683 做药物靶向肿瘤微环境方向。9月27投稿，当天QC，当天under review，11月3号decision pending，11号收到意见，两个reviewer，没有为难，小修，要求三个月修回。估计内容比较对口。husttjxusen_72292323 2017-11-16 09:51:00 发表: 做药物靶向肿瘤微环境方向。9月27投稿，当天QC，当天under review，11月3号decision pending，11号收到意见，两个reviewer，没有为难，小修，要求三个月修回。估计内容比较对口。, beContent=husttjxusen_72292323 2017-11-16 发表:: 研究方向：小分子药物;; 审稿时间：约2个月 SCI(2016)：5.764 SCI(2015)：5.579 SCI(2014)：5.683 做药物靶向肿瘤微环境方向。9月27投稿，当天QC，当天under review，11月3号decision pending，11号收到意见，两个reviewer，没有为难，小修，要求三个月修回。估计内容比较对口。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/20/4c9024110b1652c063c0636bc187da8e.jpg, createdBy=10402290533, createdName=121e5b9fm00(暂无昵称), createdTime=Wed Jan 30 00:00:00 CST 2019, time=2019-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565522, encodeId=95c5565522d3, content=CCR转投的，之前在CCR under review 后第二天被拒，转投这个，已经9天了，这个杂志一般多久送外审，或者第一轮被拒啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK0iclWFtP7WicKXLyVXAOnRibMria0BwB4otV2d2ibbbkZ2XKAvnNH5x3Y1wm9ibMNZZV5ib5qA0B99sMpw/132, createdBy=9a062530214, createdName=yelinlin, createdTime=Sun Jan 13 16:29:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565540, encodeId=6dde5655407b, content=请问同学：你文章的命运如何？sky110319 2018-11-06 发表:: 请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？sky110319 2018-11-06 15:04:00 发表: 请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？, beContent=sky110319 2018-11-06 发表:: 请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41be2522582, createdName=124e1d81m04暂无昵称, createdTime=Sun Jan 13 00:00:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562815, encodeId=83695628156d, content=请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Tue Nov 06 15:04:00 CST 2018, time=2018-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562425, encodeId=07505624255e, content=收的。一颗苹果宣布成为星球 2018-09-26 00:00:00 发表: 请问这个杂志收版面费么？, beContent=一颗苹果宣布成为星球 2018-09-26 00:00:00 发表: 请问这个杂志收版面费么？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160620/IMG5767F7B4941608075.jpg, createdBy=16081612750, createdName=nnnuclear, createdTime=Sat Oct 27 00:00:00 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561460, encodeId=e24656146004, content=对数据要求高，编辑要求提供原始没有裁剪的western blot条带, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08d5109305, createdName=zhello1234, createdTime=Wed Sep 26 07:26:00 CST 2018, time=2018-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561480, encodeId=57aa561480ed, content=请问这个杂志收版面费么？husttjxusen_72292323 2018-08-30 00:00:00 发表: 推荐, beContent=husttjxusen_72292323 2018-08-30 00:00:00 发表: 推荐, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/09/16/436a088294e7cf59c36ee2e7d817c303.jpg, createdBy=8e2c2443753, createdName=一颗苹果宣布成为星球, createdTime=Wed Sep 26 00:00:00 CST 2018, time=2018-09-26, status=1, ipAttribution=)]

2019-01-30 121e5b9fm00(暂无昵称)

请问要求提供WB原始无裁剪图吗？husttjxusen_72292323 2017-11-16 发表::
研究方向：小分子药物;; 审稿时间：约2个月 SCI(2016)：5.764 SCI(2015)：5.579 SCI(2014)：5.683 做药物靶向肿瘤微环境方向。9月27投稿，当天QC，当天under review，11月3号decision pending，11号收到意见，两个reviewer，没有为难，小修，要求三个月修回。估计内容比较对口。husttjxusen_72292323 2017-11-16 09:51:00 发表:
做药物靶向肿瘤微环境方向。9月27投稿，当天QC，当天under review，11月3号decision pending，11号收到意见，两个reviewer，没有为难，小修，要求三个月修回。估计内容比较对口。

husttjxusen_72292323 2017-11-16 发表:: 研究方向：小分子药物;; 审稿时间：约2个月 SCI(2016)：5.764 SCI(2015)：5.579 SCI(2014)：5.683 做药物靶向肿瘤微环境方向。9月27投稿，当天QC，当天under review，11月3号decision pending，11号收到意见，两个reviewer，没有为难，小修，要求三个月修回。估计内容比较对口。

156 0

[GetPortalCommentsPageByObjectIdResponse(id=568376, encodeId=8e8e5683e675, content=QC已经好几天了，还没变，请问有人遇到过这种情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d80e2509318, createdName=124b6ef5m61(暂无昵称), createdTime=Wed Mar 20 00:00:00 CST 2019, time=2019-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568115, encodeId=ad8656811550, content=请问你的QC问题最后怎么样了？我也遇到了类似的问题，不知是否正常？sky110319 2018-11-06 15:04:00 发表: 请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？, beContent=sky110319 2018-11-06 15:04:00 发表: 请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d80e2509318, createdName=124b6ef5m61(暂无昵称), createdTime=Fri Mar 15 00:00:00 CST 2019, time=2019-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566739, encodeId=0b76566e3983, content=楼下ccr转投这个太亏了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Thu Feb 14 09:50:00 CST 2019, time=2019-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566335, encodeId=e0fb566335eb, content=请问要求提供WB原始无裁剪图吗？husttjxusen_72292323 2017-11-16 发表:: 研究方向：小分子药物;; 审稿时间：约2个月 SCI(2016)：5.764 SCI(2015)：5.579 SCI(2014)：5.683 做药物靶向肿瘤微环境方向。9月27投稿，当天QC，当天under review，11月3号decision pending，11号收到意见，两个reviewer，没有为难，小修，要求三个月修回。估计内容比较对口。husttjxusen_72292323 2017-11-16 09:51:00 发表: 做药物靶向肿瘤微环境方向。9月27投稿，当天QC，当天under review，11月3号decision pending，11号收到意见，两个reviewer，没有为难，小修，要求三个月修回。估计内容比较对口。, beContent=husttjxusen_72292323 2017-11-16 发表:: 研究方向：小分子药物;; 审稿时间：约2个月 SCI(2016)：5.764 SCI(2015)：5.579 SCI(2014)：5.683 做药物靶向肿瘤微环境方向。9月27投稿，当天QC，当天under review，11月3号decision pending，11号收到意见，两个reviewer，没有为难，小修，要求三个月修回。估计内容比较对口。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/20/4c9024110b1652c063c0636bc187da8e.jpg, createdBy=10402290533, createdName=121e5b9fm00(暂无昵称), createdTime=Wed Jan 30 00:00:00 CST 2019, time=2019-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565522, encodeId=95c5565522d3, content=CCR转投的，之前在CCR under review 后第二天被拒，转投这个，已经9天了，这个杂志一般多久送外审，或者第一轮被拒啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK0iclWFtP7WicKXLyVXAOnRibMria0BwB4otV2d2ibbbkZ2XKAvnNH5x3Y1wm9ibMNZZV5ib5qA0B99sMpw/132, createdBy=9a062530214, createdName=yelinlin, createdTime=Sun Jan 13 16:29:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565540, encodeId=6dde5655407b, content=请问同学：你文章的命运如何？sky110319 2018-11-06 发表:: 请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？sky110319 2018-11-06 15:04:00 发表: 请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？, beContent=sky110319 2018-11-06 发表:: 请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41be2522582, createdName=124e1d81m04暂无昵称, createdTime=Sun Jan 13 00:00:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562815, encodeId=83695628156d, content=请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Tue Nov 06 15:04:00 CST 2018, time=2018-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562425, encodeId=07505624255e, content=收的。一颗苹果宣布成为星球 2018-09-26 00:00:00 发表: 请问这个杂志收版面费么？, beContent=一颗苹果宣布成为星球 2018-09-26 00:00:00 发表: 请问这个杂志收版面费么？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160620/IMG5767F7B4941608075.jpg, createdBy=16081612750, createdName=nnnuclear, createdTime=Sat Oct 27 00:00:00 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561460, encodeId=e24656146004, content=对数据要求高，编辑要求提供原始没有裁剪的western blot条带, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08d5109305, createdName=zhello1234, createdTime=Wed Sep 26 07:26:00 CST 2018, time=2018-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561480, encodeId=57aa561480ed, content=请问这个杂志收版面费么？husttjxusen_72292323 2018-08-30 00:00:00 发表: 推荐, beContent=husttjxusen_72292323 2018-08-30 00:00:00 发表: 推荐, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/09/16/436a088294e7cf59c36ee2e7d817c303.jpg, createdBy=8e2c2443753, createdName=一颗苹果宣布成为星球, createdTime=Wed Sep 26 00:00:00 CST 2018, time=2018-09-26, status=1, ipAttribution=)]

2019-01-13 yelinlin

CCR转投的，之前在CCR under review 后第二天被拒，转投这个，已经9天了，这个杂志一般多久送外审，或者第一轮被拒啊

169 0

[GetPortalCommentsPageByObjectIdResponse(id=568376, encodeId=8e8e5683e675, content=QC已经好几天了，还没变，请问有人遇到过这种情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d80e2509318, createdName=124b6ef5m61(暂无昵称), createdTime=Wed Mar 20 00:00:00 CST 2019, time=2019-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568115, encodeId=ad8656811550, content=请问你的QC问题最后怎么样了？我也遇到了类似的问题，不知是否正常？sky110319 2018-11-06 15:04:00 发表: 请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？, beContent=sky110319 2018-11-06 15:04:00 发表: 请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d80e2509318, createdName=124b6ef5m61(暂无昵称), createdTime=Fri Mar 15 00:00:00 CST 2019, time=2019-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566739, encodeId=0b76566e3983, content=楼下ccr转投这个太亏了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Thu Feb 14 09:50:00 CST 2019, time=2019-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566335, encodeId=e0fb566335eb, content=请问要求提供WB原始无裁剪图吗？husttjxusen_72292323 2017-11-16 发表:: 研究方向：小分子药物;; 审稿时间：约2个月 SCI(2016)：5.764 SCI(2015)：5.579 SCI(2014)：5.683 做药物靶向肿瘤微环境方向。9月27投稿，当天QC，当天under review，11月3号decision pending，11号收到意见，两个reviewer，没有为难，小修，要求三个月修回。估计内容比较对口。husttjxusen_72292323 2017-11-16 09:51:00 发表: 做药物靶向肿瘤微环境方向。9月27投稿，当天QC，当天under review，11月3号decision pending，11号收到意见，两个reviewer，没有为难，小修，要求三个月修回。估计内容比较对口。, beContent=husttjxusen_72292323 2017-11-16 发表:: 研究方向：小分子药物;; 审稿时间：约2个月 SCI(2016)：5.764 SCI(2015)：5.579 SCI(2014)：5.683 做药物靶向肿瘤微环境方向。9月27投稿，当天QC，当天under review，11月3号decision pending，11号收到意见，两个reviewer，没有为难，小修，要求三个月修回。估计内容比较对口。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/20/4c9024110b1652c063c0636bc187da8e.jpg, createdBy=10402290533, createdName=121e5b9fm00(暂无昵称), createdTime=Wed Jan 30 00:00:00 CST 2019, time=2019-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565522, encodeId=95c5565522d3, content=CCR转投的，之前在CCR under review 后第二天被拒，转投这个，已经9天了，这个杂志一般多久送外审，或者第一轮被拒啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK0iclWFtP7WicKXLyVXAOnRibMria0BwB4otV2d2ibbbkZ2XKAvnNH5x3Y1wm9ibMNZZV5ib5qA0B99sMpw/132, createdBy=9a062530214, createdName=yelinlin, createdTime=Sun Jan 13 16:29:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565540, encodeId=6dde5655407b, content=请问同学：你文章的命运如何？sky110319 2018-11-06 发表:: 请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？sky110319 2018-11-06 15:04:00 发表: 请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？, beContent=sky110319 2018-11-06 发表:: 请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41be2522582, createdName=124e1d81m04暂无昵称, createdTime=Sun Jan 13 00:00:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562815, encodeId=83695628156d, content=请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Tue Nov 06 15:04:00 CST 2018, time=2018-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562425, encodeId=07505624255e, content=收的。一颗苹果宣布成为星球 2018-09-26 00:00:00 发表: 请问这个杂志收版面费么？, beContent=一颗苹果宣布成为星球 2018-09-26 00:00:00 发表: 请问这个杂志收版面费么？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160620/IMG5767F7B4941608075.jpg, createdBy=16081612750, createdName=nnnuclear, createdTime=Sat Oct 27 00:00:00 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561460, encodeId=e24656146004, content=对数据要求高，编辑要求提供原始没有裁剪的western blot条带, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08d5109305, createdName=zhello1234, createdTime=Wed Sep 26 07:26:00 CST 2018, time=2018-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561480, encodeId=57aa561480ed, content=请问这个杂志收版面费么？husttjxusen_72292323 2018-08-30 00:00:00 发表: 推荐, beContent=husttjxusen_72292323 2018-08-30 00:00:00 发表: 推荐, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/09/16/436a088294e7cf59c36ee2e7d817c303.jpg, createdBy=8e2c2443753, createdName=一颗苹果宣布成为星球, createdTime=Wed Sep 26 00:00:00 CST 2018, time=2018-09-26, status=1, ipAttribution=)]

2019-01-13 124e1d81m04暂无昵称

请问同学：你文章的命运如何？sky110319 2018-11-06 发表::
请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？sky110319 2018-11-06 15:04:00 发表:
请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？

sky110319 2018-11-06 发表:: 请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？

149 0

[GetPortalCommentsPageByObjectIdResponse(id=568376, encodeId=8e8e5683e675, content=QC已经好几天了，还没变，请问有人遇到过这种情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d80e2509318, createdName=124b6ef5m61(暂无昵称), createdTime=Wed Mar 20 00:00:00 CST 2019, time=2019-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568115, encodeId=ad8656811550, content=请问你的QC问题最后怎么样了？我也遇到了类似的问题，不知是否正常？sky110319 2018-11-06 15:04:00 发表: 请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？, beContent=sky110319 2018-11-06 15:04:00 发表: 请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d80e2509318, createdName=124b6ef5m61(暂无昵称), createdTime=Fri Mar 15 00:00:00 CST 2019, time=2019-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566739, encodeId=0b76566e3983, content=楼下ccr转投这个太亏了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Thu Feb 14 09:50:00 CST 2019, time=2019-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566335, encodeId=e0fb566335eb, content=请问要求提供WB原始无裁剪图吗？husttjxusen_72292323 2017-11-16 发表:: 研究方向：小分子药物;; 审稿时间：约2个月 SCI(2016)：5.764 SCI(2015)：5.579 SCI(2014)：5.683 做药物靶向肿瘤微环境方向。9月27投稿，当天QC，当天under review，11月3号decision pending，11号收到意见，两个reviewer，没有为难，小修，要求三个月修回。估计内容比较对口。husttjxusen_72292323 2017-11-16 09:51:00 发表: 做药物靶向肿瘤微环境方向。9月27投稿，当天QC，当天under review，11月3号decision pending，11号收到意见，两个reviewer，没有为难，小修，要求三个月修回。估计内容比较对口。, beContent=husttjxusen_72292323 2017-11-16 发表:: 研究方向：小分子药物;; 审稿时间：约2个月 SCI(2016)：5.764 SCI(2015)：5.579 SCI(2014)：5.683 做药物靶向肿瘤微环境方向。9月27投稿，当天QC，当天under review，11月3号decision pending，11号收到意见，两个reviewer，没有为难，小修，要求三个月修回。估计内容比较对口。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/20/4c9024110b1652c063c0636bc187da8e.jpg, createdBy=10402290533, createdName=121e5b9fm00(暂无昵称), createdTime=Wed Jan 30 00:00:00 CST 2019, time=2019-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565522, encodeId=95c5565522d3, content=CCR转投的，之前在CCR under review 后第二天被拒，转投这个，已经9天了，这个杂志一般多久送外审，或者第一轮被拒啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK0iclWFtP7WicKXLyVXAOnRibMria0BwB4otV2d2ibbbkZ2XKAvnNH5x3Y1wm9ibMNZZV5ib5qA0B99sMpw/132, createdBy=9a062530214, createdName=yelinlin, createdTime=Sun Jan 13 16:29:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565540, encodeId=6dde5655407b, content=请问同学：你文章的命运如何？sky110319 2018-11-06 发表:: 请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？sky110319 2018-11-06 15:04:00 发表: 请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？, beContent=sky110319 2018-11-06 发表:: 请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41be2522582, createdName=124e1d81m04暂无昵称, createdTime=Sun Jan 13 00:00:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562815, encodeId=83695628156d, content=请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Tue Nov 06 15:04:00 CST 2018, time=2018-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562425, encodeId=07505624255e, content=收的。一颗苹果宣布成为星球 2018-09-26 00:00:00 发表: 请问这个杂志收版面费么？, beContent=一颗苹果宣布成为星球 2018-09-26 00:00:00 发表: 请问这个杂志收版面费么？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160620/IMG5767F7B4941608075.jpg, createdBy=16081612750, createdName=nnnuclear, createdTime=Sat Oct 27 00:00:00 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561460, encodeId=e24656146004, content=对数据要求高，编辑要求提供原始没有裁剪的western blot条带, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08d5109305, createdName=zhello1234, createdTime=Wed Sep 26 07:26:00 CST 2018, time=2018-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561480, encodeId=57aa561480ed, content=请问这个杂志收版面费么？husttjxusen_72292323 2018-08-30 00:00:00 发表: 推荐, beContent=husttjxusen_72292323 2018-08-30 00:00:00 发表: 推荐, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/09/16/436a088294e7cf59c36ee2e7d817c303.jpg, createdBy=8e2c2443753, createdName=一颗苹果宣布成为星球, createdTime=Wed Sep 26 00:00:00 CST 2018, time=2018-09-26, status=1, ipAttribution=)]

2018-11-06 sky110319

请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？

171 0

[GetPortalCommentsPageByObjectIdResponse(id=568376, encodeId=8e8e5683e675, content=QC已经好几天了，还没变，请问有人遇到过这种情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d80e2509318, createdName=124b6ef5m61(暂无昵称), createdTime=Wed Mar 20 00:00:00 CST 2019, time=2019-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568115, encodeId=ad8656811550, content=请问你的QC问题最后怎么样了？我也遇到了类似的问题，不知是否正常？sky110319 2018-11-06 15:04:00 发表: 请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？, beContent=sky110319 2018-11-06 15:04:00 发表: 请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d80e2509318, createdName=124b6ef5m61(暂无昵称), createdTime=Fri Mar 15 00:00:00 CST 2019, time=2019-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566739, encodeId=0b76566e3983, content=楼下ccr转投这个太亏了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Thu Feb 14 09:50:00 CST 2019, time=2019-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566335, encodeId=e0fb566335eb, content=请问要求提供WB原始无裁剪图吗？husttjxusen_72292323 2017-11-16 发表:: 研究方向：小分子药物;; 审稿时间：约2个月 SCI(2016)：5.764 SCI(2015)：5.579 SCI(2014)：5.683 做药物靶向肿瘤微环境方向。9月27投稿，当天QC，当天under review，11月3号decision pending，11号收到意见，两个reviewer，没有为难，小修，要求三个月修回。估计内容比较对口。husttjxusen_72292323 2017-11-16 09:51:00 发表: 做药物靶向肿瘤微环境方向。9月27投稿，当天QC，当天under review，11月3号decision pending，11号收到意见，两个reviewer，没有为难，小修，要求三个月修回。估计内容比较对口。, beContent=husttjxusen_72292323 2017-11-16 发表:: 研究方向：小分子药物;; 审稿时间：约2个月 SCI(2016)：5.764 SCI(2015)：5.579 SCI(2014)：5.683 做药物靶向肿瘤微环境方向。9月27投稿，当天QC，当天under review，11月3号decision pending，11号收到意见，两个reviewer，没有为难，小修，要求三个月修回。估计内容比较对口。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/20/4c9024110b1652c063c0636bc187da8e.jpg, createdBy=10402290533, createdName=121e5b9fm00(暂无昵称), createdTime=Wed Jan 30 00:00:00 CST 2019, time=2019-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565522, encodeId=95c5565522d3, content=CCR转投的，之前在CCR under review 后第二天被拒，转投这个，已经9天了，这个杂志一般多久送外审，或者第一轮被拒啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK0iclWFtP7WicKXLyVXAOnRibMria0BwB4otV2d2ibbbkZ2XKAvnNH5x3Y1wm9ibMNZZV5ib5qA0B99sMpw/132, createdBy=9a062530214, createdName=yelinlin, createdTime=Sun Jan 13 16:29:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565540, encodeId=6dde5655407b, content=请问同学：你文章的命运如何？sky110319 2018-11-06 发表:: 请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？sky110319 2018-11-06 15:04:00 发表: 请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？, beContent=sky110319 2018-11-06 发表:: 请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41be2522582, createdName=124e1d81m04暂无昵称, createdTime=Sun Jan 13 00:00:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562815, encodeId=83695628156d, content=请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Tue Nov 06 15:04:00 CST 2018, time=2018-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562425, encodeId=07505624255e, content=收的。一颗苹果宣布成为星球 2018-09-26 00:00:00 发表: 请问这个杂志收版面费么？, beContent=一颗苹果宣布成为星球 2018-09-26 00:00:00 发表: 请问这个杂志收版面费么？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160620/IMG5767F7B4941608075.jpg, createdBy=16081612750, createdName=nnnuclear, createdTime=Sat Oct 27 00:00:00 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561460, encodeId=e24656146004, content=对数据要求高，编辑要求提供原始没有裁剪的western blot条带, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08d5109305, createdName=zhello1234, createdTime=Wed Sep 26 07:26:00 CST 2018, time=2018-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561480, encodeId=57aa561480ed, content=请问这个杂志收版面费么？husttjxusen_72292323 2018-08-30 00:00:00 发表: 推荐, beContent=husttjxusen_72292323 2018-08-30 00:00:00 发表: 推荐, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/09/16/436a088294e7cf59c36ee2e7d817c303.jpg, createdBy=8e2c2443753, createdName=一颗苹果宣布成为星球, createdTime=Wed Sep 26 00:00:00 CST 2018, time=2018-09-26, status=1, ipAttribution=)]

2018-10-27 nnnuclear

收的。一颗苹果宣布成为星球 2018-09-26 00:00:00 发表:
请问这个杂志收版面费么？

一颗苹果宣布成为星球 2018-09-26 00:00:00 发表: 请问这个杂志收版面费么？

184 0

[GetPortalCommentsPageByObjectIdResponse(id=568376, encodeId=8e8e5683e675, content=QC已经好几天了，还没变，请问有人遇到过这种情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d80e2509318, createdName=124b6ef5m61(暂无昵称), createdTime=Wed Mar 20 00:00:00 CST 2019, time=2019-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568115, encodeId=ad8656811550, content=请问你的QC问题最后怎么样了？我也遇到了类似的问题，不知是否正常？sky110319 2018-11-06 15:04:00 发表: 请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？, beContent=sky110319 2018-11-06 15:04:00 发表: 请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d80e2509318, createdName=124b6ef5m61(暂无昵称), createdTime=Fri Mar 15 00:00:00 CST 2019, time=2019-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566739, encodeId=0b76566e3983, content=楼下ccr转投这个太亏了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Thu Feb 14 09:50:00 CST 2019, time=2019-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566335, encodeId=e0fb566335eb, content=请问要求提供WB原始无裁剪图吗？husttjxusen_72292323 2017-11-16 发表:: 研究方向：小分子药物;; 审稿时间：约2个月 SCI(2016)：5.764 SCI(2015)：5.579 SCI(2014)：5.683 做药物靶向肿瘤微环境方向。9月27投稿，当天QC，当天under review，11月3号decision pending，11号收到意见，两个reviewer，没有为难，小修，要求三个月修回。估计内容比较对口。husttjxusen_72292323 2017-11-16 09:51:00 发表: 做药物靶向肿瘤微环境方向。9月27投稿，当天QC，当天under review，11月3号decision pending，11号收到意见，两个reviewer，没有为难，小修，要求三个月修回。估计内容比较对口。, beContent=husttjxusen_72292323 2017-11-16 发表:: 研究方向：小分子药物;; 审稿时间：约2个月 SCI(2016)：5.764 SCI(2015)：5.579 SCI(2014)：5.683 做药物靶向肿瘤微环境方向。9月27投稿，当天QC，当天under review，11月3号decision pending，11号收到意见，两个reviewer，没有为难，小修，要求三个月修回。估计内容比较对口。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/20/4c9024110b1652c063c0636bc187da8e.jpg, createdBy=10402290533, createdName=121e5b9fm00(暂无昵称), createdTime=Wed Jan 30 00:00:00 CST 2019, time=2019-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565522, encodeId=95c5565522d3, content=CCR转投的，之前在CCR under review 后第二天被拒，转投这个，已经9天了，这个杂志一般多久送外审，或者第一轮被拒啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK0iclWFtP7WicKXLyVXAOnRibMria0BwB4otV2d2ibbbkZ2XKAvnNH5x3Y1wm9ibMNZZV5ib5qA0B99sMpw/132, createdBy=9a062530214, createdName=yelinlin, createdTime=Sun Jan 13 16:29:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565540, encodeId=6dde5655407b, content=请问同学：你文章的命运如何？sky110319 2018-11-06 发表:: 请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？sky110319 2018-11-06 15:04:00 发表: 请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？, beContent=sky110319 2018-11-06 发表:: 请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41be2522582, createdName=124e1d81m04暂无昵称, createdTime=Sun Jan 13 00:00:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562815, encodeId=83695628156d, content=请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Tue Nov 06 15:04:00 CST 2018, time=2018-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562425, encodeId=07505624255e, content=收的。一颗苹果宣布成为星球 2018-09-26 00:00:00 发表: 请问这个杂志收版面费么？, beContent=一颗苹果宣布成为星球 2018-09-26 00:00:00 发表: 请问这个杂志收版面费么？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160620/IMG5767F7B4941608075.jpg, createdBy=16081612750, createdName=nnnuclear, createdTime=Sat Oct 27 00:00:00 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561460, encodeId=e24656146004, content=对数据要求高，编辑要求提供原始没有裁剪的western blot条带, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08d5109305, createdName=zhello1234, createdTime=Wed Sep 26 07:26:00 CST 2018, time=2018-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561480, encodeId=57aa561480ed, content=请问这个杂志收版面费么？husttjxusen_72292323 2018-08-30 00:00:00 发表: 推荐, beContent=husttjxusen_72292323 2018-08-30 00:00:00 发表: 推荐, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/09/16/436a088294e7cf59c36ee2e7d817c303.jpg, createdBy=8e2c2443753, createdName=一颗苹果宣布成为星球, createdTime=Wed Sep 26 00:00:00 CST 2018, time=2018-09-26, status=1, ipAttribution=)]

2018-09-26 zhello1234

对数据要求高，编辑要求提供原始没有裁剪的western blot条带

145 0

[GetPortalCommentsPageByObjectIdResponse(id=568376, encodeId=8e8e5683e675, content=QC已经好几天了，还没变，请问有人遇到过这种情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d80e2509318, createdName=124b6ef5m61(暂无昵称), createdTime=Wed Mar 20 00:00:00 CST 2019, time=2019-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568115, encodeId=ad8656811550, content=请问你的QC问题最后怎么样了？我也遇到了类似的问题，不知是否正常？sky110319 2018-11-06 15:04:00 发表: 请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？, beContent=sky110319 2018-11-06 15:04:00 发表: 请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d80e2509318, createdName=124b6ef5m61(暂无昵称), createdTime=Fri Mar 15 00:00:00 CST 2019, time=2019-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566739, encodeId=0b76566e3983, content=楼下ccr转投这个太亏了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Thu Feb 14 09:50:00 CST 2019, time=2019-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566335, encodeId=e0fb566335eb, content=请问要求提供WB原始无裁剪图吗？husttjxusen_72292323 2017-11-16 发表:: 研究方向：小分子药物;; 审稿时间：约2个月 SCI(2016)：5.764 SCI(2015)：5.579 SCI(2014)：5.683 做药物靶向肿瘤微环境方向。9月27投稿，当天QC，当天under review，11月3号decision pending，11号收到意见，两个reviewer，没有为难，小修，要求三个月修回。估计内容比较对口。husttjxusen_72292323 2017-11-16 09:51:00 发表: 做药物靶向肿瘤微环境方向。9月27投稿，当天QC，当天under review，11月3号decision pending，11号收到意见，两个reviewer，没有为难，小修，要求三个月修回。估计内容比较对口。, beContent=husttjxusen_72292323 2017-11-16 发表:: 研究方向：小分子药物;; 审稿时间：约2个月 SCI(2016)：5.764 SCI(2015)：5.579 SCI(2014)：5.683 做药物靶向肿瘤微环境方向。9月27投稿，当天QC，当天under review，11月3号decision pending，11号收到意见，两个reviewer，没有为难，小修，要求三个月修回。估计内容比较对口。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/20/4c9024110b1652c063c0636bc187da8e.jpg, createdBy=10402290533, createdName=121e5b9fm00(暂无昵称), createdTime=Wed Jan 30 00:00:00 CST 2019, time=2019-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565522, encodeId=95c5565522d3, content=CCR转投的，之前在CCR under review 后第二天被拒，转投这个，已经9天了，这个杂志一般多久送外审，或者第一轮被拒啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK0iclWFtP7WicKXLyVXAOnRibMria0BwB4otV2d2ibbbkZ2XKAvnNH5x3Y1wm9ibMNZZV5ib5qA0B99sMpw/132, createdBy=9a062530214, createdName=yelinlin, createdTime=Sun Jan 13 16:29:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565540, encodeId=6dde5655407b, content=请问同学：你文章的命运如何？sky110319 2018-11-06 发表:: 请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？sky110319 2018-11-06 15:04:00 发表: 请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？, beContent=sky110319 2018-11-06 发表:: 请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41be2522582, createdName=124e1d81m04暂无昵称, createdTime=Sun Jan 13 00:00:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562815, encodeId=83695628156d, content=请问各位，QC7已经天了，正常吗？该杂志还需要交审稿费吗？请问在哪里找？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Tue Nov 06 15:04:00 CST 2018, time=2018-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562425, encodeId=07505624255e, content=收的。一颗苹果宣布成为星球 2018-09-26 00:00:00 发表: 请问这个杂志收版面费么？, beContent=一颗苹果宣布成为星球 2018-09-26 00:00:00 发表: 请问这个杂志收版面费么？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160620/IMG5767F7B4941608075.jpg, createdBy=16081612750, createdName=nnnuclear, createdTime=Sat Oct 27 00:00:00 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561460, encodeId=e24656146004, content=对数据要求高，编辑要求提供原始没有裁剪的western blot条带, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08d5109305, createdName=zhello1234, createdTime=Wed Sep 26 07:26:00 CST 2018, time=2018-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561480, encodeId=57aa561480ed, content=请问这个杂志收版面费么？husttjxusen_72292323 2018-08-30 00:00:00 发表: 推荐, beContent=husttjxusen_72292323 2018-08-30 00:00:00 发表: 推荐, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/09/16/436a088294e7cf59c36ee2e7d817c303.jpg, createdBy=8e2c2443753, createdName=一颗苹果宣布成为星球, createdTime=Wed Sep 26 00:00:00 CST 2018, time=2018-09-26, status=1, ipAttribution=)]

2018-09-26 一颗苹果宣布成为星球

请问这个杂志收版面费么？husttjxusen_72292323 2018-08-30 00:00:00 发表:
推荐

husttjxusen_72292323 2018-08-30 00:00:00 发表: 推荐

238 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务